BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18615424)

  • 1. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
    Okamura N; Masuda T; Gotoh A; Shirakawa T; Terao S; Kaneko N; Suganuma K; Watanabe M; Matsubara T; Seto R; Matsumoto J; Kawakami M; Yamamori M; Nakamura T; Yagami T; Sakaeda T; Fujisawa M; Nishimura O; Okumura K
    Proteomics; 2008 Aug; 8(15):3194-203. PubMed ID: 18615424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panel of candidate biomarkers for renal cell carcinoma.
    Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
    J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine-glycine amidinotransferase, betaine-homocysteine S-methyltransferase, and neuropolypeptide H3 are diminished in renal clear cell carcinoma of humans.
    Peng JP; Zhang J; Huang HW; Wang FH; Du XJ; Luo PC
    Saudi Med J; 2011 May; 32(5):467-73. PubMed ID: 21556466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].
    Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
    Sun CY; Zang YC; San YX; Sun W; Zhang L
    Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of nuclear matrix protein alterations associated with renal cell carcinoma.
    Cannon GM; Balasudramani M; Getzenberg RH
    Urology; 2007 Jun; 69(6):1227-30. PubMed ID: 17572229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
    Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
    J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.
    Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N
    Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
    Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
    Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.
    Negishi A; Masuda M; Ono M; Honda K; Shitashige M; Satow R; Sakuma T; Kuwabara H; Nakanishi Y; Kanai Y; Omura K; Hirohashi S; Yamada T
    Cancer Sci; 2009 Sep; 100(9):1605-11. PubMed ID: 19522851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example.
    Chang JT; Chen LC; Wei SY; Chen YJ; Wang HM; Liao CT; Chen IH; Cheng AJ
    Clin Biochem; 2006 Dec; 39(12):1144-51. PubMed ID: 17014837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
    J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
    Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
    Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
    Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
    Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
    Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
    Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.